Micropaque (Barium Sulfate)

Barium sulfate is an insoluble, radiopaque compound that absorbs X‑ray photons. When introduced into the gastrointestinal lumen, it creates a dense layer that blocks X‑rays, producing a stark contrast between the barium‑filled tract and surrounding tissues, which enables detailed imaging of the GI system.

The dose of Micropaque is determined by the prescribing physician based on the specific imaging procedure, patient age, weight, and clinical condition. The healthcare professional selects the appropriate volume and concentration to achieve optimal radiographic contrast.

Safety of Micropaque in pregnancy and lactation has not been established. It should be used only when clearly necessary and after a risk‑benefit assessment by the treating physician. Breastfeeding mothers should consult their doctor before exposure.

To order Micropaque, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Micropaque (barium sulfate) is a high‑density, non‑ionic, water‑insoluble contrast medium, offering superior radiopacity for gastrointestinal studies compared with iodine‑based agents, which are typically used for vascular or soft‑tissue imaging. Barium provides longer-lasting coating but is not suitable for patients with suspected perforation.

Micropaque should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Ensure the suspension is well‑mixed before administration and avoid contamination.

Micropaque is administered orally as a liquid suspension for upper GI studies or rectally as an enema for lower GI examinations. The exact volume and method are directed by the radiologist or physician performing the imaging procedure.

Serious risks include bowel obstruction, gastrointestinal perforation, severe allergic reactions (anaphylaxis), aspiration leading to pneumonitis, and significant electrolyte disturbances. Immediate medical attention is required if any of these events occur during or after the procedure.

Micropaque is contraindicated in patients with known or suspected gastrointestinal perforation, severe bowel obstruction, hypersensitivity to barium sulfate, or those unable to tolerate the required volume of contrast. Clinicians should also exercise caution in pregnant or lactating women and in patients with compromised renal function.